User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 8 results.
    • Journal article
    Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
    Pivot, X. Awada, A. Gedouin, D Kerger, Joseph Rolland, F Cupissol, D Caponigro, F Comella, G Lopez-Pousa, JJ Guardiola, E Giroux, B Gerard, Benoît[UCL] Schneider, A (2003) Annals of Oncology — Vol. 14, no. 3, p. 373-377 (2003)
    • Speech
    High serum galectin-3 in advanced melanoma: preliminary results
    Vereecken, P Boudjeltia, KZ Debray, C Awada, A. Legssyer, I Sales, F Petein, M. Vanhaeverbeek, M. Ghanem, G. Heenen, M (2006) Meeting on Perspectives in Melanoma VIII — Berlin(Germany)
    • Speech
    A dose-escalating study of XRP6258 in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy: Preliminary results
    Besse-Hammer, T.[UCL] Machiels, Jean-Pascal[UCL] Villanueva, C.[UCL] Campone, M.[UCL] Awada, A.[UCL] Magherini, E.[UCL] Dubin, F.[UCL] Semiond, D.[UCL] Pivot, X. B.[UCL] (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology — Orlando (Fl)
    • Speech
    Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors
    Vereecken, P Debray, C Petein, M. Awada, A. Lalmand, MC Laporte, M Van Den Heule, B Verhest, A. Pochet, R Heenen, M (2005) Fall Meeting of the Melanoma-Group of the European-Organization-for-Research-and-Treatment-of-Cancer — Berlin(Germany)
    • Journal article
    EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): 5 years of European collaboration in new drug development for breast cancer
    Awada, A. VanVreckem, A Paridaens, Robert[UCL] Bruning, PF Klijn, J Tomiak, E Vinholes, J Roy, JA Kusenda, Z Boes, GH Vanglabbeke, M. Piccart, Martine (1997) European Journal of Cancer — Vol. 33, no. 8, p. 1173-1176 (1997)
    • Journal article
    A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment : a phase I/II study
    Villanueva, C. Awada, A. Campone, M. Machiels, Jean-Pascal[UCL] Besse, T. Magherini, E. Dubin, F. Semiond, D. Pivot, X. (2011) European Journal of Cancer — Vol. 47, no. 7, p. 1037-1045 (2011)
    • Speech
    Fulvestrant in heavily pretreated patients with advanced breast cancer: A Belgium cooperative study.
    Neven, Patrick[UCL] Paridaens, Robert[UCL] Pelgrims, G. Martens, M. Bols, A. Goeminne, J. C. Vindevoghel, A. Demol, J. Stragier, B. De Greve, J. Schallier, D. Van Den Weyngaert, D. Becquart, D. Borms, M. Cocquyt, V. Van Den Broecke, R. Selleslags, J. Awada, A. Dirix, L. Van Dam, P. Azerad, M. A. Vandenhoven, G. Christianes, M. R. Vergote, Antoine[UCL] (2006) 29th Annual San Antonio Breast Cancer Symposium — San Antonio(Tx)
    • Speech
    A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy
    Villanueva, C. Awada, A. Campone, M. Machiels, Jean-Pascal[UCL] Besse, T. Magherini, E. Dubin, F. Semiond, D. Pivot, X. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)